MYMX - myomixer, myoblast fusion factor Gene

Also Known as CFZS2; MINION; hMINION

Species: Homo sapiens

Gene Type: protein coding
Gene ID: 101929726

About MYMX

Cytogenetic location: 6p21.1 Genomic coordinates (GRCh38): 6:44,192,721-44,218,234 (from NCBI)

This gene has 2 transcripts (splice variants) and 62 orthologues. Biased expression in fat (RPKM 1.3), stomach (RPKM 0.3) and 7 other tissues.

Summary

Predicted to be involved in myoblast fusion involved in skeletal muscle regeneration; plasma membrane fusion; and skeletal muscle organ development. Predicted to be integral component of plasma membrane. Predicted to be active in Golgi membrane; endoplasmic reticulum membrane; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

MYMX Products (2)

mRNA Protein Name
NM_001315494.2 NP_001302423.1 protein myomixer precursor
NM_001347931.2 NP_001334860.1 protein myomixer precursor

Gene Ontology

  • Biological Process
Biological Process GO Annotation Evidence References Source
involved in myoblast fusion IGI
IGI: Inferred from genetic interaction
28569745 GOA
involved in myoblast fusion involved in skeletal muscle regeneration IMP
IMP: Inferred from mutant phenotype
35642635 GOA
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

protein myomixer

  • microprotein inducer of fusion

Related Diseases

Diseases Alias
Carey-Fineman-Ziter Syndrome 2

  • CFZS2
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

  • Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-RS08928 MYMX Human Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Canis familiaris MYMX VGNC VGNC:54973
Mus musculus MYMX MGD MGI:3649059
Felis catus MYMX VGNC VGNC:102473
Rattus norvegicus MYMX RGD RGD:11426996
Others MYMX NCBI